Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International journal of pharmaceutics

• Publication date

  2009-10-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijpharm.2009.07.022PMID 19646515
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides.

  2009cited by this paper
• Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation.

  2009cited by this paper
• Effect of cell-penetrating peptides on the nasal absorption of insulin.

  2009cited by this paper
• Homeoproteins as natural Penetratin cargoes with signaling properties.

  2008cited by this paper
• Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration.

  2008cited by this paper
• Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery.

  2008cited by this paper
• Usefulness of cell-penetrating peptides to improve intestinal insulin absorption.

  2008cited by this paper
• High affinity of the cell-penetrating peptide HIV-1 Tat-PTD for DNA.

  2007cited by this paper
• Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells.

  2007cited by this paper
• Assessing the delivery efficacy and internalization route of cell-penetrating peptides

  2007cited by this paper
• Current challenges in non-invasive insulin delivery systems: a comparative review.

  2007cited by this paper
• all-D proline-rich cell-penetrating peptides: a preliminary in vivo internalization study.

  2007cited by this paper
• A novel approach using functional peptides for efficient intestinal absorption of insulin.

  2007cited by this paper
• Intranasal delivery: physicochemical and therapeutic aspects.

  2007cited by this paper
• Peptide drug delivery strategies for the treatment of diabetes.

  2007cited by this paper
• Approaches to oral drug delivery for challenging molecules.

  2006cited by this paper
• Novel delivery technologies for protein and peptide therapeutics.

  2006cited by this paper
• Protein transduction: cell penetrating peptides and their therapeutic applications.

  2006cited by this paper
• Effects of absorption promoters on insulin absorption through colon-targeted delivery.

  2006cited by this paper
• Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.

  2006cited by this paper
• Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats.

  2006cited by this paper
• Therapeutic peptides: technological advances driving peptides into development.

  2006cited by this paper
• Is the oral route possible for peptide and protein drug delivery?

  2006cited by this paper
• Exenatide in type 2 diabetes: treatment effects in clinical studies and animal study data

  2006cited by this paper
• Binding of oligoarginine to membrane lipids and heparan sulfate: structural and thermodynamic characterization of a cell-penetrating peptide.

  2005cited by this paper
• Characterisation of cell‐penetrating peptide‐mediated peptide delivery

  2005cited by this paper
• Membrane interaction and cellular internalization of penetratin peptides.

  2004influential reference
• Therapeutic strategies based on glucagon-like peptide 1.

  2004cited by this paper
• Vesicle membrane interactions of penetratin analogues.

  2004cited by this paper
• Chances and pitfalls of cell penetrating peptides for cellular drug delivery.

  2004cited by this paper
• Nasal route and drug delivery systems

  2004cited by this paper
• Challenges for the oral delivery of macromolecules

  2003cited by this paper
• Nasal drug delivery--possibilities, problems and solutions.

  2003cited by this paper
• Peptide-mediated cell delivery: application in protein target validation.

  2002cited by this paper
• Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles

  2002cited by this paper
• Synthetic long-chain alkyl maltosides and alkyl sucrose esters as enhancers of nasal insulin absorption.

  2002cited by this paper
• In vivo protein transduction: delivery of a biologically active protein into the mouse.

  1999cited by this paper
• GLP-1 Tablet in Type 2 Diabetes in Fasting and Postprandial Conditions

  1997cited by this paper
• Intestinal absorption and excretion of octapeptides composed of D amino acids.

  1994cited by this paper
• Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

  1993influential reference
• Enzymatic barriers to peptide and protein absorption.

  1988cited by this paper
• Bioavailability of Propranolol After Oral, Sublingual, and Intranasal Administration

  1986cited by this paper
• Comparison of water influx and sieving coefficient in rat jejunal, rectal and nasal absorptions of antipyrine.

  1985cited by this paper
• Mechanisms for the enhancement of the nasal absorption of insulin by surfactants

  1981cited by this paper

• Nasal irrigation for drug delivery in adults

  2025cites this paper
• Intranasal Absorption Enhancement of Antidiabetic Therapeuticals by the Functional Peptide Segment of Latroeggtoxin-VI.

  2025cites this paper
• Branched penetratin and penetramax display enhanced intestinal insulin delivery potency compared to their linear counterparts.

  2025cites this paper
• Cell-penetrating peptides for transmucosal delivery of proteins.

  2024cites this paper
• Nanomedicines for intranasal delivery: understanding the nano-bio interactions at the nasal mucus-mucosal barrier

  2024cites this paper
• Mucosa-penetrating liposomes for esophageal local drug delivery.

  2024cites this paper
• PEPTIDE DELIVERY VIA NASAL ROUTE: EXPLORING RECENT DEVELOPMENTS AND APPROACHES

  2024cites this paper
• Unlocking Genome Editing: Advances and Obstacles in CRISPR/Cas Delivery Technologies

  2024cites this paper
• Stereochemistry and Intermolecular Interactions Influence Carrier Peptide-Mediated Insulin Delivery.

  2023cites this paper
• Recent Advances of Cell-Penetrating Peptides and Their Application as Vectors for Delivery of Peptide and Protein-Based Cargo Molecules

  2023cites this paper
• Stereoisomer-Dependent Membrane Association and Capacity for Insulin Delivery Facilitated by Penetratin

  2023cites this paper
• A Comprehensive Review of Advanced Nasal Delivery: Specially Insulin and Calcitonin.

  2023cites this paper
• A large-volume low-pressure nasal irrigation delivers drug into the nasal cavity? An in vivo study

  2023cites this paper
• Challenges and Opportunities in the Oral Delivery of Recombinant Biologics

  2023cites this paper
• Solid lipid nanoparticles: a promising tool for insulin delivery

  2022cites this paper
• Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides

  2022cites this paper
• Screening for effective cell-penetrating peptides with minimal impact on epithelial cells and gut commensals in vitro

  2022cites this paper
• Engineering of Smart Nanoconstructs for Delivery of Glucagon-like Peptide-1 Analogs.

  2021cites this paper
• Effects of intestinal luminal contents and the importance of microfold cells on the ability of cell-penetrating peptides to enhance epithelial permeation of insulin.

  2020cites this paper
• Cell-penetrating peptides (CPPs): an overview of applications for improving the potential of nanotherapeutics.

  2020cites this paper
• Evaluation of Cell-Penetrating Peptides as Versatile, Effective Absorption Enhancers: Relation to Molecular Weight and Inherent Epithelial Drug Permeability

  2020cites this paper
• Systemic and brain delivery of leptin via intranasal coadministration with cell-penetrating peptides and its therapeutic potential for obesity.

  2020cites this paper
• Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability

  2019cites this paper
• Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles

  2019influential citation
• Protein Delivery and Mimicry

  2019cites this paper
• Materials for oral delivery of proteins and peptides

  2019cites this paper
• Disassembling a cancer puzzle: Cell junctions and plasma membrane as targets for anticancer therapy

  2018cites this paper
• Stereochemistry as a determining factor for the effect of a cell-penetrating peptide on cellular viability and epithelial integrity.

  2018cites this paper
• Hydrophobic Amino Acid Tryptophan Shows Promise as a Potential Absorption Enhancer for Oral Delivery of Biopharmaceuticals

  2018cites this paper
• Acid‐sensitive hybrid polymeric micelles containing a reversibly activatable cell‐penetrating peptide for tumor‐specific cytoplasm targeting

  2018cites this paper
• Oral delivery of anti‐diabetes therapeutics using cell penetrating and transcytosing peptide strategies

  2018cites this paper
• Biocompatible Polymers Modified with d-Octaarginine as an Absorption Enhancer for Nasal Peptide Delivery.

  2018cites this paper
• Nose-to-Brain Delivery of Peptide Drugs Enhanced by Coadministration of Cell-penetrating Peptides: Therapeutic Potential for Dementia.

  2017cites this paper
• Effect of an Enhanced Nose-to-Brain Delivery of Insulin on Mild and Progressive Memory Loss in the Senescence-Accelerated Mouse.

  2017cites this paper
• Novel strategies in the oral delivery of antidiabetic peptide drugs – Insulin, GLP 1 and its analogs

  2017cites this paper
• Nose-to-brain peptide delivery - The potential of nanotechnology.

  2017cites this paper
• On the design of tailored liposomes for KRX29 peptide delivery

  2017cites this paper
• Development of METx: a Vasopressin Agonist

  2017cites this paper
• Intestinal permeation enhancers for oral peptide delivery.

  2016cites this paper
• Use of a non-covalent cell-penetrating peptide strategy to enhance the nasal delivery of interferon beta and its PEGylated form.

  2016cites this paper
• Cell-Penetrating Peptides as Carriers for Oral Delivery of Biopharmaceuticals.

  2016cites this paper
• Potential of Translationally Controlled Tumor Protein-Derived Protein Transduction Domains as Antigen Carriers for Nasal Vaccine Delivery.

  2016cites this paper
• Delivery of Therapeutic Proteins: Challenges and Strategies.

  2016cites this paper
• Applications and Challenges for Use of Cell-Penetrating Peptides as Delivery Vectors for Peptide and Protein Cargos

  2016influential citation
• Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.

  2016cites this paper
• Cell-Penetrating Peptide Penetratin as a Potential Tool for Developing Effective Nasal Vaccination Systems.

  2016cites this paper
• 剤形の進歩：GLP―1およびインスリンの非注射製剤の開発動向

  2016cites this paper
• Membrane Oxidation Governed Direct Plasma Membrane Translocation of Cell-Penetrating Peptides in Live Cells: Mechanisms and Implications

  2016cites this paper
• Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals

  2016influential citation
• Oral insulin delivery – challenges and strategies

  2015cites this paper
• Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane

  2015cites this paper
• Natural and Synthetic Polymers as Drug Carriers for Delivery of Therapeutic Proteins

  2015cites this paper
• Safety of the cell-penetrating peptide penetratin as an oral absorption enhancer.

  2015cites this paper
• Co-administration with cell penetrating peptide enhances the oral bioavailability of docetaxel-loaded nanoparticles

  2015cites this paper
• Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides.

  2015cites this paper
• Drug delivery across the nasal mucosa

  2014cites this paper
• Rational design of CPP-based drug delivery systems: considerations from pharmacokinetics.

  2014cites this paper
• Intranasal Glucagon

  2014cites this paper
• In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin.

  2014cites this paper
• CPP mediated insulin delivery: current status and promising future.

  2014cites this paper
• Formulation strategies to improve oral peptide delivery.

  2014cites this paper
• CPP-mediated protein delivery in a noncovalent form: proof-of-concept for percutaneous and intranasal delivery.

  2014cites this paper
• Epithelial Permeation and Absorption Mechanisms of Biopharmaceuticals

  2014cites this paper
• Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery.

  2014cites this paper
• Approaches for enhancing oral bioavailability of peptides and proteins.

  2013cites this paper
• One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats.

  2013cites this paper
• Bioportides: Bioactive cell‐penetrating peptides that modulate cellular dynamics

  2013cites this paper
• Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport.

  2013cites this paper
• Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin.

  2013cites this paper
• Determination of the optimal cell-penetrating peptide sequence for intestinal insulin delivery based on molecular orbital analysis with self-organizing maps.

  2013cites this paper
• Peptide-enhanced oral delivery of therapeutic peptides and proteins

  2013cites this paper
• Developing oral formulations for protein and peptide drugs

  2013cites this paper
• Treatment of human cells derived from MERRF syndrome by peptide-mediated mitochondrial delivery.

  2013cites this paper
• Noninvasive insulin delivery: the great potential of cell-penetrating peptides.

  2013cites this paper
• The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorption.

  2013cites this paper
• Performance of cell-penetrating peptide-linked polymers physically mixed with poorly membrane-permeable molecules on cell membranes.

  2012cites this paper
• Skin-permeable quaternary nanoparticles with layer-by-layer structure enabling improved gene delivery

  2012cites this paper
• Cell-penetrating Peptide-biodrug Strategy for Oral and Nasal Delivery: Review of Recent Findings

  2012cites this paper
• Excipients with specialized functions for effective drug delivery

  2012cites this paper
• Strategies for non-invasive delivery of biologics

  2012cites this paper
• Oral biodrug delivery using cell-penetrating peptide.

  2012influential citation
• Investigation of transport mechanism of exendin-4 across Madin Darby canine kidney cell monolayers.

  2012cites this paper
• Polioviral receptor binding ligand: A novel and safe peptide drug carrier from polioviral capsid

  2012influential citation
• [Potential of cell penetrating peptides for cell drug delivery].

  2011cites this paper
• Noninvasive delivery of therapeutic peptides and proteins using cell-penetrating peptides

  2010cites this paper
• PERSPECTIVES ON NANOPARTICULATE DELIVERY OF THERAPEUTIC PROTEINS BY ORAL ADMINISTRATION

  2010cites this paper
• The role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptides.

  2010cites this paper
• Structural requirements of penetratin absorption enhancement efficiency for insulin delivery.

  2010cites this paper